Apoprotein (a) antagonises the GPIIb/IIIa receptor on collagen and ADP-stimulated human platelets

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 404-410

  Barre, D Edward ^a  

^a CAPE BRETON UNIVERSITY   (Canada)

Author keywords

Apolipoprotein(a); GPIIb IIIa antagonism; Human; Lipoprotein(a); Platelet

Indexed keywords

ADENOSINE DIPHOSPHATE; APOLIPOPROTEIN A; BUFFER; COLLAGEN; FIBRINOGEN RECEPTOR; LIPOPROTEIN A; MONOCLONAL ANTIBODY;

AFFINITY CHROMATOGRAPHY; ARTICLE; HUMAN; IC 50; NONHUMAN; PROTEIN BINDING; PROTEIN INTERACTION; SIMULATION; THROMBOCYTE; THROMBOCYTE AGGREGATION; BINDING COMPETITION; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; METABOLISM;

ADENOSINE DIPHOSPHATE; APOLIPOPROTEINS A; BINDING, COMPETITIVE; BLOOD PLATELETS; COLLAGEN; DRUG INTERACTIONS; HUMANS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 1642334187     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1194     Document Type: Article

References (47)

1. Mbewu A.D. & P.N. Durrington: Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis, 85, 1-14 (1990)
2. Dujurovic S & K. Berg: Epidemiology of lipoprotein (a): its role in atherosclerotic/thrombotic disease. Clin Genet, 52, 281-292 (1997)
3. Danesh J, R. Collins & R. Peto: Lipoprotein (a) and coronary heart disease. Meta analysis of prospective studies. Circulation, 102, 1082-1085 (2000)
4. Schalich M.P., S. John, M.R.W. Langenfeld, K.J. Lackner, G. Schmitz & R.E. Schmieder: Does Lipoprotein (a) impair endothelial function? J. Am. Coll. Cardiol, 31, 359-365 (1998)
5. Dahlen G.H. & H. Stenlund: Lp (a) lipoprotein is a major risk factor for cardiovascular disease. Clin. Genet, 52, 272-280 (1997)
6. Cheng S.W.K., A.C.W. Ting & J. Wong: Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular. Eur. J. Vasc. Endovasc. Surg, 14, 17-23 (1997)
7. Miles L.A. & E.F. Plow: An interloper into the fibrinolytic system. Thromb Haemostas, 63, 331-335 (1990)
8. Franchesini G., E. Cofrancesco, O. Safa, C. Boschetti, E. Tremoli, L. Mussoni, C.R. Sirtori & M. Cortellaro: Association of lipoprotein (a) with atherothrombotic events and fibrinolytic variables. A case-control study. Thromb. Res. 78, 227-238 (1995)
9. Scanu A.M: Lipoprotein (a): its inheritance and molecular basis of its atherothrombotic role. Molec. Cell Biochem, 113, 127-131 (1992)
10. Dahlen C.A.: Lipoprotein (a), atherosclerosis and thrombosis. Prog. Lipid Res, 30, 189-194 (1991)
11. Eaton D.L., G.M. Fless, W.J. Kohr, J.W. McLean, Q-T. Xu, C.J. Millar, R.M. Lawn & A.M. Scanu: Partial amino acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc. Natl. Acad. Sci, 84, 3224-3228 (1987)
12. McLean J.W., J.E. Tomlinson, W-J. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu & R.M. Lawn: cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature, 330, 132-137 (1987)
13. Loscazlo J., M. Weinfeld, G.M. Fless & A.M. Scanu: Lipoprotein (a), fibrin binding and plasminogen activation. Arteriosclerosis, 10, 240-245 (1990)
14. Edelberg, J.M., Pizzo, S.V. 1991. Lipoprotein a. inhibits plasminogen activation in a template-dependent manner. Blood Coag Fibrinol. 2, 759-764.
15. Milionis H., D.P. Mikhailidis & A.F. Winder: Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosis. Platelets 10, 277-284 (1999)
16. Mao S.J.T. & M.A. Tucci: Lipoprotein (a) enhances plasma clot lysis in vitro. Febs. Letters. 267, 131-134 (1990)
17. Testa, R., Marcovina, S.M. 1999. The rate of plasmin formation after in vitro clotting is inversely related to lipoprotein a. levels. Intl J. Lab Clin Res. 29, 128-132.
18. Collen D., D.C. Stump & H.K. Gold: Thrombolytic therapy. Annu Rev Med, 39, 405-423 (1988)
19. nd edition pp 1393-1437. (1989)
20. Miller J.L., A.J. Katz & M.B. Feinstein: Plasmin inhibition of thrombin-induced platelet aggregation. Thromb. Diath. Hemorrh, 33, 286-309 (1975)
21. Huby T., J. Chapman & J. Thillet: Pathophysiological implication of the structural domains of lipoprotein (a). Atherosclerosis, 133, 1-6 (1997)
22. Guevara J., R.D. Knapp, S. Honda, S.R. Northup & J. D. Morrisett: A structural assessment of the apo (a) protein of human lipoprotein (a). Proteins: structure, function and genetics, 12, 188-199 (1992)
23. Hajjar K.A. & R.L. Nachman: The role of lipoprotein (a) in atherogenesis and thrombosis. Ann. Rev. Med, 47, 423-442 (1996)
24. Karmansky, I. & N. Gruener: Structure and Possible Biological Roles of Lp (a). Clin Biochem. 27, 151-162 (1994)
25. 2 production. Platelets, 9, 93-96 (1998)
26. Gries A., M. Gries, H. Wurm, T. Kenner, M. Ijsseldijk, J. J. Sixma & G.M. Kostner: Lipoprotein (a) inhibits collagen-induced aggregation of thrombocytes. Arterio. Thromb. Vasc. Biol. 16, 648-655 (1996)
27. Barre, D.E., D. Usher, D. Rader & J. B. Moberly: Lp(a) inhibits platelet aggregation by antagonizing the fibrinogen (GPIIb/IIIa) receptor. Circulation 98.: Suppl I: 525 Abstract number 2754 (1998)
28. Gaubatz J.W., C. Heidernan, A.M. Gotto Jr., J.D. Morrisett & G.H. Dahlen: Human plasma lipoprotein [a] structural properties. J. Biol. Chem. 258, 4582-4589 (1983)
29. Gaubatz J.W., M.V. Chad, M.L. Nava, J.R. Guyton & J.D. Morrisett: Isolation and characterization of the two major apoproteins in human lipoprotein[a]. J. Lipid Res, 28, 69-79 (1987)
30. Fless G.M., M.E. ZumMallen & A.M. Scanu: Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein(a). J. Biol. Chem. 261, 8712-8718 (1986)
31. Kratzin H., V.W. Armstrong, M. Niehaus, N. Hilschmann & D. Seidel: Structural relationship of an apolipoprotein (a) phenotype (570 kDs) to plasminogen: Homologous kringle domains are linked by carbohydrate-rich regions. Biol. Chem. Hoppes-Seyler, 368, 1533-1544 (1987)
32. Malle E., A. Ibovnik, A. Steinmetz, G.M. Kostner & W. Sattler: Identification of Glycoprotein IIb as the lipoprotein (a)-binding protein on platelets. Lipoprotein (a) binding is independent of an arginyl-glycyl-asparale tripeptide located in apolipoprotein (a). Arterio. Thromb. 14, 345-352 (1994)
33. 1 integrin and GP VI. J. Biol. Chem. 274, 11897-11903 (1999)
34. Bennett J.S. & G. Vilaire: Exposure of platelet fibrinogen receptors to ADP and epinephrine. J. Clin. Invest. 64, 1393-1401 (1979)
35. Shattil S.J., J.A. Hoxie, M. Cunningham & L.F. Brass: Changes in platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J. Biol. Chem, 260, 11107-11114 (1985)
36. Shattil S.J: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies. Blood, 70, 307-315 (1987)
37. Seman L.J., C. de Luca & J.L. Jenner: Isolation and purification of serum lipoprotein (a) using lectin affinity. Methods in Molec. Biol. 110, 131-136 (1998)
38. Armstrong V.W., A.K. Wall & D. Seidel: Isolation, characterization and uptake of human fibroblasts and of apo (a)-free lipoprotein obtained on reduction of Lp (a). J. Lipid Res. 26, 1314-23 (1985)
39. Sinn H.J., H.H. Schrenk, E.A. Friedrich, D.P. Via & H.A. Dresel: Radioiodination of proteins and lipoproteins using n-bromosuccinamide as oxidizing agents. Anal. Biochem. 170, 186-192 (1998)
40. Lowry O.H., N.J. Rosebrough, A.L. Farr & R.L. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275. (1951)
41. Aster R.H. & J.H. Jandl: Platelet sequestration in man. I. Methods. J. Clin. Invest. 43, 843-55 (1964)
42. Mustard J.F., D.W. Perry, N.G. Ardlie & M.A. Packham: Preparation of suspensions of washed platelets from humans. Brit. J. Haematol, 22, 193-204 (1972)
43. Born, G.V.R.: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 194, 927-930 (1962)
44. Mustard J.F., M.A. Packham, R.L. Kinlough-Tathbone, D.W. Perry & E. Regoeczi: Fibrinogen and ADP-induced platelet aggregation. Blood 52, 453-466 (1978)
45. Phillips D.R., I.F. Charo, L.V. Parise & L.A. Fitzgerald: The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831-843 (1988)
46. Bennett J.S.: Platelet-fibrinogen interactions. Ann. N.Y. Acad. Sci. 936, 340-354 (2001)
47. Keidar S., M. Aviram, E. Grenadier & W. Markiewicz: Arterial blood derived low density lipoprotein increases platelet aggregation and macrophage cholesterol content in comparison to lipoprotein derived from venous blood. Artery 16:62-71 (1989)